These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [Study of the changes in protein-lipid components of blood lipoproteins and the dynamics of coronary arteriosclerosis based on repeated angiographic examination]. Nechaev AS; Gratsianskiĭ NA; Olfer'ev AM; Metel'skaia VA; Mazaev VP Kardiologiia; 1989 Apr; 29(4):16-21. PubMed ID: 2754908 [No Abstract] [Full Text] [Related]
3. [Study of changes in the protein-lipid components of blood lipoproteins and the dynamics of coronary arteriosclerosis based on repeated angiographic examinations]. Nechaev AS Biull Vsesoiuznogo Kardiol Nauchn Tsentra AMN SSSR; 1989; 12(1):93. PubMed ID: 2742772 [No Abstract] [Full Text] [Related]
4. [The correlation of the lipoprotein (a) level of the blood serum with the degree of coronary atherosclerosis]. Olofinskaia IE; Adamova IIu; Susekov AV; Volkova EI; Afanas'eva OI; Liakishev AA; Pokrovskiĭ SN; Savchenko AP Ter Arkh; 1992; 64(7):100-3. PubMed ID: 1440353 [No Abstract] [Full Text] [Related]
5. Plasma levels of HDL subpopulations and remnant lipoproteins predict the extent of angiographically-defined coronary artery disease in postmenopausal women. Lamon-Fava S; Herrington DM; Reboussin DM; Sherman M; Horvath KV; Cupples LA; White C; Demissie S; Schaefer EJ; Asztalos BF Arterioscler Thromb Vasc Biol; 2008 Mar; 28(3):575-9. PubMed ID: 18174456 [TBL] [Abstract][Full Text] [Related]
6. [Lipoprotein (a) plasma levels in normal subjects and patients with coronary disease confirmed by coronary cineangiography]. Maranhäo R; Arie S; Vinagre CG; Guimarães JB; Strunz C; Pileggi F Arq Bras Cardiol; 1991 Feb; 56(2):121-5. PubMed ID: 1831344 [TBL] [Abstract][Full Text] [Related]
7. Relationship between endogenous sex hormone levels, lipoproteins and coronary atherosclerosis in men undergoing coronary angiography. Kabakci G; Yildirir A; Can I; Unsal I; Erbas B Cardiology; 1999; 92(4):221-5. PubMed ID: 10844380 [TBL] [Abstract][Full Text] [Related]
8. [Serum copper levels in patients with acute and chronic types of ischemic heart disease and its relation to lipoprotein levels and extent of coronary atherosclerosis]. Málek F; Karel I; Polásek R; Spacek R; Lisa L; Dvorák J; Stanka P Vnitr Lek; 2000 Oct; 46(10):693-6. PubMed ID: 11344628 [TBL] [Abstract][Full Text] [Related]
9. [Relation of serum apolipoprotein and lipoprotein and coronary atherosclerosis]. Morimoto S; Hiasa Y; Maeda T; Harada M; Wada T; Aihara T; Bando M; Nakai Y; Kataoka Y; Mori H Kokyu To Junkan; 1986 Nov; 34(11):1221-6. PubMed ID: 3809751 [No Abstract] [Full Text] [Related]
10. Plasma lipoproteins are not related to restenosis after successful coronary angioplasty. Rozenman Y; Gilon D; Welber S; Sapoznikov D; Lotan C; Geist M; Weiss AT; Hasin Y; Gotsman MS Am J Cardiol; 1993 Nov; 72(15):1206-7. PubMed ID: 8237817 [No Abstract] [Full Text] [Related]
11. [Plasma lipoproteins and coronary arteriosclerosis]. Sznajderman M Przegl Lek; 1987; 44(6):508-9. PubMed ID: 3685436 [No Abstract] [Full Text] [Related]
13. Postprandial lipoproteins and progression of coronary atherosclerosis. Karpe F; Steiner G; Uffelman K; Olivecrona T; Hamsten A Atherosclerosis; 1994 Mar; 106(1):83-97. PubMed ID: 8018110 [TBL] [Abstract][Full Text] [Related]
14. Treatment effects on serum lipoprotein lipids, apolipoproteins and low density lipoprotein particle size and relationships of lipoprotein variables to progression of coronary artery disease in the Bezafibrate Coronary Atherosclerosis Intervention Trial (BECAIT). Ruotolo G; Ericsson CG; Tettamanti C; Karpe F; Grip L; Svane B; Nilsson J; de Faire U; Hamsten A J Am Coll Cardiol; 1998 Nov; 32(6):1648-56. PubMed ID: 9822092 [TBL] [Abstract][Full Text] [Related]
15. Role of triglyceride-rich lipoproteins in progression of atherosclerosis. Havel RJ Circulation; 1990 Feb; 81(2):694-6. PubMed ID: 2297871 [No Abstract] [Full Text] [Related]
16. Associations between lipoproteins and the progression of coronary and vein-graft atherosclerosis in a controlled trial with gemfibrozil in men with low baseline levels of HDL cholesterol. Syvänne M; Nieminen MS; Frick MH; Kauma H; Majahalme S; Virtanen V; Kesäniemi YA; Pasternack A; Ehnholm C; Taskinen MR Circulation; 1998 Nov; 98(19):1993-9. PubMed ID: 9808595 [TBL] [Abstract][Full Text] [Related]
17. Triglyceride- and cholesterol-rich lipoproteins have a differential effect on mild/moderate and severe lesion progression as assessed by quantitative coronary angiography in a controlled trial of lovastatin. Hodis HN; Mack WJ; Azen SP; Alaupovic P; Pogoda JM; LaBree L; Hemphill LC; Kramsch DM; Blankenhorn DH Circulation; 1994 Jul; 90(1):42-9. PubMed ID: 8026027 [TBL] [Abstract][Full Text] [Related]
18. Intermediate lipoproteins, atherosclerosis, and Gofman. Soloff LA Circulation; 1998 Feb; 97(7):708. PubMed ID: 9495311 [No Abstract] [Full Text] [Related]